The following text field will produce suggestions that follow it as you type.

Barnes and Noble

The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into Crisis What We Can Do About It

Current price: $24.99
The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into Crisis What We Can Do About It
The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into Crisis What We Can Do About It

Barnes and Noble

The Problem of Alzheimer's: How Science, Culture, and Politics Turned a Rare Disease into Crisis What We Can Do About It

Current price: $24.99

Size: Audiobook

Loading Inventory...
CartBuy Online
*Product information may vary - to confirm product availability, pricing, shipping and return information please contact Barnes and Noble
A
definitive and compelling book on one of today's most prevalent illnesses.
In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050.
Part case studies, part meditation on the past, present and future of the disease,
The Problem of Alzheimer's
traces Alzheimer’s from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems’ failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer’s to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life.
Rich in science, history, and characters,
takes us inside laboratories, patients' homes, caregivers’ support groups, progressive care communities, and Jason Karlawish's own practice at the Penn Memory Center. It also includes a new epilogue recounting the FDA’s surprising 2021 approval of the controversial Alzheimer’s drug Aduhelm, the astonishing aftermath, and how these unique events explain the enduring problem of Alzheimer’s.

More About Barnes and Noble at The Summit

With an excellent depth of book selection, competitive discounting of bestsellers, and comfortable settings, Barnes & Noble is an excellent place to browse for your next book.

Powered by Adeptmind